Portage Biotech Inc. (PRTG)
7.43
-0.83 (-10.05%)
At close: Apr 02, 2025, 3:59 PM
6.42
-13.59%
After-hours: Apr 02, 2025, 07:55 PM EDT
-10.05% (1D)
| Bid | 6.55 |
| Market Cap | 8.33M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -68.17 |
| PE Ratio (ttm) | -0.11 |
| Forward PE | -9.04 |
| Analyst | n/a |
| Ask | 7 |
| Volume | 155,872 |
| Avg. Volume (20D) | 613,975 |
| Open | 7.49 |
| Previous Close | 8.26 |
| Day's Range | 6.55 - 8.10 |
| 52-Week Range | 2.10 - 23.01 |
| Beta | 1.61 |
About PRTG
Portage Biotech Inc., together with its subsidiaries, researches and develops pharmaceutical and biotechnology products. The company's product includes IMM60, an iNKT cell activator; IMM65, a PLGA-nanoparticle combined with a NY-ESO-1 peptide vaccine; INT230-6 that is in Phase I/II clinical trials for the treatment of solid tumors; STING, a small molecule that binds to the stimulator of interferon genes in cancer; CellPorter, a cell permeable pep...
Industry Biotechnology
Sector Healthcare
IPO Date Jan 2, 2002
Employees 7
Stock Exchange NASDAQ
Ticker Symbol PRTG
Website https://www.portagebiotech.com
6 days ago
+103.82%
Portage Biotech shares are trading higher after th...
Unlock content with
Pro Subscription
6 days ago
+3.74%
Portage Biotech shares are trading higher after the company reported new data for PORT-7 at the 2025 European Lung Cancer Congress.
